Success Stories: EB-1A Approved for a Senior Scientist from India With the Help of Our Supporting Team
Client’s Testimonial:
"I sincerely appreciate your efforts and support with my EB1A application.”
On October 2nd, 2020, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Scientist in the Field of Pharmaceutical Sciences (Approval Notice).
General Field: Pharmaceutical Sciences
Position at the Time of Case Filing: Senior Scientist
Country of Origin: India
State of Residence at the Time of Filing: Pennsylvania
Approval Notice Date: October 2nd, 2020
Processing Time: 7 months, 10 days
A senior scientist from India, holding a Ph.D. in pharmaceutical sciences engaged us to compose an EB-1A (Alien of Extraordinary Ability) petition on his behalf. As a part of our legal strategy, we asked him to provide us with the required relevant documents to get him to achieve the EB1A approval. Based on the wealth of information we gathered, we determined our client’s research background, expertise field, and further achievements, confirming his extraordinary ability to continue his research work here in the U.S. Thus, we counter-signed the attorney-client agreement and prepared our client’s petition letter highlighting his extraordinary ability in the field.
- We described his research on the use of lipid-based drug delivery systems and solid dispersions to develop novel pharmaceutical products and how it addresses some of our nation’s most pressing issues in understanding the successful methods for administering soluble and effective drugs for various prominent healthcare conditions.
- Also, we noted the 10 peer-reviewed scientific articles published by him in some of the impacting journals in his field. We observed that he not only conducted important original research but his work is also considered crucially significant by the editors of the top journals in the field. Further, we recorded that he is an active peer-reviewed in the scientific community for prestigious journals, and he has already conducted 22 reviews.
- In addition, we detailed the 152 citations his work amassed at the time of filing, and his article citation rates are between 2.18 and 16.67 times higher than the average number of citations in the field for their respective publication years, distinguishing him from other researchers in the field.
- Moreover, we attached five recommendation letters in his case to support the petition further. The letters were acquired by our client from fellow experts in the field, asserting our client’s expertise and experience in contributing significantly to the field of pharmaceutical sciences here in the U.S. One of the recommenders remarked:
We successfully convinced the USCIS that our client is an asset to the United States, hence our client achieved his EB-1A approval drawing him one step closer to obtaining a green card. We thank him for letting us represent his EB-1A application and be a part of this success story.